Sotac Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	57.67	80.27	42.81	28.79	28.79
Depreciation & Amortization	54.06	38.3	30.95	22.76	11.26
Other Amortization	-	0.05	0.05	0.02	0.01
Loss (Gain) From Sale of Assets	-0.7	-	-	-	-
Loss (Gain) From Sale of Investments	-	-	-1.29	-	18.36
Other Operating Activities	48.95	47.15	-26.22	14.13	4.24
Change in Accounts Receivable	11.62	-78.25	-115.47	38.11	-62.71
Change in Inventory	-68.16	-22.51	-43.68	-44.65	-15.96
Change in Accounts Payable	82.47	-99.49	35	-47.85	94.27
Change in Other Net Operating Assets	-17.23	-8.84	-82.93	70.12	-14.76
Operating Cash Flow	168.67	-43.31	-160.76	81.43	63.51
Operating Cash Flow Growth	-	-	-	28.22%	-
Capital Expenditures	-63.9	-170.16	-177.89	-90	-35.04
Sale of Property, Plant & Equipment	0.8	0.03	0.09	13.14	-
Investment in Securities	8.66	-16.86	-20.96	-40.02	-0.59
Other Investing Activities	-14.53	50.83	1.8	0.46	0.48
Investing Cash Flow	-68.98	-136.16	-196.79	-116.74	-35.15
Short-Term Debt Issued	-	167.78	-	31.07	24.56
Long-Term Debt Issued	34.57	20.63	43.62	6.54	-
Total Debt Issued	34.57	188.41	43.62	37.61	24.56
Short-Term Debt Repaid	-	-	-15.42	-	-
Long-Term Debt Repaid	-95.6	-	-	-	-17.48
Total Debt Repaid	-95.6	-	-15.42	-	-17.48
Net Debt Issued (Repaid)	-61.03	188.41	28.2	37.61	7.08
Issuance of Common Stock	-	-	333	112.66	-
Common Dividends Paid	-1.11	-	-	-	-4.6
Other Financing Activities	-41.42	-27.48	-66.29	-18.9	-30.78
Financing Cash Flow	-103.55	160.93	294.91	131.36	-28.3
Miscellaneous Cash Flow Adjustments	-	-	-	0	-
Net Cash Flow	-3.86	-18.54	-62.64	96.05	0.05
Free Cash Flow	104.77	-213.47	-338.65	-8.57	28.46
Free Cash Flow Margin	10.31%	-21.29%	-32.57%	-1.11%	3.89%
Free Cash Flow Per Share	9.48	-19.32	-30.85	-1.06	3.54
Cash Interest Paid	-	22.32	15.23	18.64	5.32
Cash Income Tax Paid	-	8.05	16.91	16.84	18.59
Levered Free Cash Flow	48.62	-263.43	-323.71	-54.33	-10.71
Unlevered Free Cash Flow	74.42	-249.47	-314.02	-42.44	-7.57
Change in Working Capital	8.69	-209.08	-207.07	15.73	0.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.